Navigation Links
New Infographic from Premier Allergy Is 'Nothing To Sneeze At'
Date:7/16/2013

Dublin, Ohio (PRWEB) July 16, 2013

Dr. Summit Shah, lead allergist at Premier Allergy, announces a new infographic to help educate the public about allergy statistics. The infographic is entitled "Allergies Are Nothing To Sneeze At" and includes valuable information about allergens, statistics, costs, and treatment options.

"We think infographics are a great way to condense a lot of important information," says Dr. Shah, the Ohio allergist behind the design. "It’s just one way of conveying information to the public that helps them really think about something they may be experiencing. We published the infographic as a way to inform people of what allergies are and how you can treat them."

The graphic is laid out in different sections. The first section talks about the science of sneezing and what can set it off. In addition to pollens and dander, triggers such as bright sunlight or exercise can actually cause one to sneeze. The second section is about allergy facts, showing how different allergens come at different times of the year as well as some statistics about how many Americans suffer from symptoms. The third section shows the costs related to allergy problems: an estimated $14.5 billion. Over 30,000 emergency room visits are due to an allergic reaction. It’s the number two reason why adults call out of work and symptoms keep over 40% of children from being active.

The final section talks about allergy treatment options. From over the counter and prescription medications to allergy shots and rush immunotherapy, there’s information on how each can be helpful to those who suffer seasonal symptoms. Premier Allergy provides these and other treatments and procedures for all kinds of allergens like pollen, dander, food, medicines, and chemicals. They work with both children and adults to help alleviate seasonal symptoms and educate individuals about their unique situation.

"No matter which treatment option you choose, we encourage people to contact an Ohio allergist from our practice," says Dr. Shah. "Allergy sufferers can really benefit from visiting a member of our staff. We can create a customized treatment plan to help manage your allergies."

To meet with an allergist in the Ohio area or to learn more about what is offered at Premier Allergy, prospective patients can visit http://www.premierallergyohio.com/ or visit one of their eight convenient locations. Click here to view Premier Allergy’s infographic, "Allergies Are Nothing To Sneeze At."

About Premier Allergy

Dr. Summit Shah is the lead allergist at Premier Allergy. As the winner of the prestigious America’s Top Allergist award and medical advisor to the “My” Food Allergy Support Group, he is committed to helping patients find relief from all types of allergies, including food allergies and environmental allergies. Premier Allergy also has seven other convenient locations in the Columbus area.

Read the full story at http://www.prweb.com/releases/columbus-allergist/premier-allergy/prweb10917619.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Tummy Calm Infographic Outlines Stomachache Causes in Children
2. Father's Day Infographic Release by 123Greetings.com: Are Fathers Underrated
3. Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines
4. Auto Accident Infographic Issued by d’Oliveira & Associates on Steps to Take After a Car Crash
5. Michigan Car Accident Lawyer at Buckfire & Buckfire, P.C. Creates Drunk Driving Deaths Infographic
6. Infographic by INTIMINA Brings Incontinence Out in the Open
7. Da Vinci Robotic Infographic Released by d’Oliveira & Associates Expresses Concerns over Surgical Device
8. Tekturna Infographic Released by d’Oliveira & Associates Imparts Potential Side Effects of Blood Pressure Drug
9. St Jude Retreats Releases New Infographic Which Reports Consequences of Drunk Driving
10. d'Oliveira & Associates Issues New Infographic on Xarelto Providing Current FDA and Medical Study Information
11. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... , ... Journal of Oral Implantology – Tooth loss is not ... health, including complications with speech, eating, and overcompensation of mouth due to the deficiency. ... As the number of tooth replacements increase, it is imperative to design an implant ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete ... has been honored by Enterprising Women magazine as one of its 2017 Enterprising ... women business owners. Winners have demonstrated that they have fast-growth businesses, mentor or ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... RawTrition now ... easy way to get nutrients from SUPERFOODS! , RawTrition is taking nutrients ... the cellular level because the body recognizes its raw form (unlike the synthetically made ...
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne research, ... cells) Phase I/II HOPE clinical trial in Duchenne announced today. , Coalition ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology: